Pharma & Healthcare
Global Drugs for Schistosomiasis Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 16, 25
- ID: 189241
- Pages: 80
- Figures: 76
- Views: 33
The global Drugs for Schistosomiasis market size was US$ 88.3 million in 2024 and is forecast to a readjusted size of US$ 114 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
The global Drugs for Schistosomiasis market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
By Type: (Dominant Segment vs High-Margin Innovation)
Praziquantel
Oxamniquine
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Shin Poong in Europe)
- Emerging Product Trends: Praziquantel adoption vs. Oxamniquine premiumization
- Demand-Side Dynamics: S. haematobium growth in China vs. S. mansoni potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
South Korea
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Drugs for Schistosomiasis market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Oxamniquine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., S. mansoni in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Praziquantel dominance in Europe vs. Oxamniquine demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
The global Drugs for Schistosomiasis market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
By Type: (Dominant Segment vs High-Margin Innovation)
Praziquantel
Oxamniquine
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Shin Poong in Europe)
- Emerging Product Trends: Praziquantel adoption vs. Oxamniquine premiumization
- Demand-Side Dynamics: S. haematobium growth in China vs. S. mansoni potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
South Korea
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Drugs for Schistosomiasis market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Oxamniquine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., S. mansoni in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Praziquantel dominance in Europe vs. Oxamniquine demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Drugs for Schistosomiasis Product Scope
1.2 Drugs for Schistosomiasis by Type
1.2.1 Global Drugs for Schistosomiasis Sales by Type (2020 & 2024 & 2031)
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Drugs for Schistosomiasis by Application
1.3.1 Global Drugs for Schistosomiasis Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Global Drugs for Schistosomiasis Market Estimates and Forecasts (2020-2031)
1.4.1 Global Drugs for Schistosomiasis Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Drugs for Schistosomiasis Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Drugs for Schistosomiasis Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Drugs for Schistosomiasis Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Drugs for Schistosomiasis Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Drugs for Schistosomiasis Sales Market Share by Region (2020-2025)
2.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Region (2020-2025)
2.3 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Drugs for Schistosomiasis Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Drugs for Schistosomiasis Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
2.4.2 Europe Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
2.4.3 China Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
2.4.4 Japan Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
2.4.5 India Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
2.4.6 South Korea Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Drugs for Schistosomiasis Historic Market Review by Type (2020-2025)
3.1.1 Global Drugs for Schistosomiasis Sales by Type (2020-2025)
3.1.2 Global Drugs for Schistosomiasis Revenue by Type (2020-2025)
3.1.3 Global Drugs for Schistosomiasis Price by Type (2020-2025)
3.2 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Drugs for Schistosomiasis Sales Forecast by Type (2026-2031)
3.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Type (2026-2031)
3.2.3 Global Drugs for Schistosomiasis Price Forecast by Type (2026-2031)
3.3 Different Types Drugs for Schistosomiasis Representative Players
4 Global Market Size by Application
4.1 Global Drugs for Schistosomiasis Historic Market Review by Application (2020-2025)
4.1.1 Global Drugs for Schistosomiasis Sales by Application (2020-2025)
4.1.2 Global Drugs for Schistosomiasis Revenue by Application (2020-2025)
4.1.3 Global Drugs for Schistosomiasis Price by Application (2020-2025)
4.2 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Drugs for Schistosomiasis Sales Forecast by Application (2026-2031)
4.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Application (2026-2031)
4.2.3 Global Drugs for Schistosomiasis Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Drugs for Schistosomiasis Application
5 Competition Landscape by Players
5.1 Global Drugs for Schistosomiasis Sales by Players (2020-2025)
5.2 Global Top Drugs for Schistosomiasis Players by Revenue (2020-2025)
5.3 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2024)
5.4 Global Drugs for Schistosomiasis Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Drugs for Schistosomiasis, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Drugs for Schistosomiasis, Product Type & Application
5.7 Global Key Manufacturers of Drugs for Schistosomiasis, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Drugs for Schistosomiasis Sales by Company
6.1.1.1 North America Drugs for Schistosomiasis Sales by Company (2020-2025)
6.1.1.2 North America Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.1.2 North America Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.1.3 North America Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.1.4 North America Drugs for Schistosomiasis Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Drugs for Schistosomiasis Sales by Company
6.2.1.1 Europe Drugs for Schistosomiasis Sales by Company (2020-2025)
6.2.1.2 Europe Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.2.2 Europe Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.2.3 Europe Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.2.4 Europe Drugs for Schistosomiasis Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Drugs for Schistosomiasis Sales by Company
6.3.1.1 China Drugs for Schistosomiasis Sales by Company (2020-2025)
6.3.1.2 China Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.3.2 China Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.3.3 China Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.3.4 China Drugs for Schistosomiasis Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Drugs for Schistosomiasis Sales by Company
6.4.1.1 Japan Drugs for Schistosomiasis Sales by Company (2020-2025)
6.4.1.2 Japan Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.4.2 Japan Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.4.3 Japan Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.4.4 Japan Drugs for Schistosomiasis Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Drugs for Schistosomiasis Sales by Company
6.5.1.1 India Drugs for Schistosomiasis Sales by Company (2020-2025)
6.5.1.2 India Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.5.2 India Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.5.3 India Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.5.4 India Drugs for Schistosomiasis Major Customer
6.5.5 India Market Trend and Opportunities
6.6 South Korea Market: Players, Segments, Downstream and Major Customers
6.6.1 South Korea Drugs for Schistosomiasis Sales by Company
6.6.1.1 South Korea Drugs for Schistosomiasis Sales by Company (2020-2025)
6.6.1.2 South Korea Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.6.2 South Korea Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.6.3 South Korea Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.6.4 South Korea Drugs for Schistosomiasis Major Customer
6.6.5 South Korea Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Shin Poong
7.1.1 Shin Poong Company Information
7.1.2 Shin Poong Business Overview
7.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Shin Poong Drugs for Schistosomiasis Products Offered
7.1.5 Shin Poong Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Business Overview
7.2.3 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Merck Drugs for Schistosomiasis Products Offered
7.2.5 Merck Recent Development
7.3 Bayer
7.3.1 Bayer Company Information
7.3.2 Bayer Business Overview
7.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Bayer Drugs for Schistosomiasis Products Offered
7.3.5 Bayer Recent Development
7.4 EIPICO
7.4.1 EIPICO Company Information
7.4.2 EIPICO Business Overview
7.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.4.4 EIPICO Drugs for Schistosomiasis Products Offered
7.4.5 EIPICO Recent Development
7.5 Chandra Bhagat Pharma
7.5.1 Chandra Bhagat Pharma Company Information
7.5.2 Chandra Bhagat Pharma Business Overview
7.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Products Offered
7.5.5 Chandra Bhagat Pharma Recent Development
7.6 Taj Pharmaceuticals
7.6.1 Taj Pharmaceuticals Company Information
7.6.2 Taj Pharmaceuticals Business Overview
7.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Products Offered
7.6.5 Taj Pharmaceuticals Recent Development
8 Drugs for Schistosomiasis Manufacturing Cost Analysis
8.1 Drugs for Schistosomiasis Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Drugs for Schistosomiasis
8.4 Drugs for Schistosomiasis Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Drugs for Schistosomiasis Distributors List
9.3 Drugs for Schistosomiasis Customers
10 Drugs for Schistosomiasis Market Dynamics
10.1 Drugs for Schistosomiasis Industry Trends
10.2 Drugs for Schistosomiasis Market Drivers
10.3 Drugs for Schistosomiasis Market Challenges
10.4 Drugs for Schistosomiasis Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Drugs for Schistosomiasis Product Scope
1.2 Drugs for Schistosomiasis by Type
1.2.1 Global Drugs for Schistosomiasis Sales by Type (2020 & 2024 & 2031)
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Drugs for Schistosomiasis by Application
1.3.1 Global Drugs for Schistosomiasis Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Global Drugs for Schistosomiasis Market Estimates and Forecasts (2020-2031)
1.4.1 Global Drugs for Schistosomiasis Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Drugs for Schistosomiasis Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Drugs for Schistosomiasis Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Drugs for Schistosomiasis Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Drugs for Schistosomiasis Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Drugs for Schistosomiasis Sales Market Share by Region (2020-2025)
2.2.2 Global Drugs for Schistosomiasis Revenue Market Share by Region (2020-2025)
2.3 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Drugs for Schistosomiasis Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Drugs for Schistosomiasis Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
2.4.2 Europe Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
2.4.3 China Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
2.4.4 Japan Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
2.4.5 India Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
2.4.6 South Korea Drugs for Schistosomiasis Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Drugs for Schistosomiasis Historic Market Review by Type (2020-2025)
3.1.1 Global Drugs for Schistosomiasis Sales by Type (2020-2025)
3.1.2 Global Drugs for Schistosomiasis Revenue by Type (2020-2025)
3.1.3 Global Drugs for Schistosomiasis Price by Type (2020-2025)
3.2 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Drugs for Schistosomiasis Sales Forecast by Type (2026-2031)
3.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Type (2026-2031)
3.2.3 Global Drugs for Schistosomiasis Price Forecast by Type (2026-2031)
3.3 Different Types Drugs for Schistosomiasis Representative Players
4 Global Market Size by Application
4.1 Global Drugs for Schistosomiasis Historic Market Review by Application (2020-2025)
4.1.1 Global Drugs for Schistosomiasis Sales by Application (2020-2025)
4.1.2 Global Drugs for Schistosomiasis Revenue by Application (2020-2025)
4.1.3 Global Drugs for Schistosomiasis Price by Application (2020-2025)
4.2 Global Drugs for Schistosomiasis Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Drugs for Schistosomiasis Sales Forecast by Application (2026-2031)
4.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Application (2026-2031)
4.2.3 Global Drugs for Schistosomiasis Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Drugs for Schistosomiasis Application
5 Competition Landscape by Players
5.1 Global Drugs for Schistosomiasis Sales by Players (2020-2025)
5.2 Global Top Drugs for Schistosomiasis Players by Revenue (2020-2025)
5.3 Global Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2024)
5.4 Global Drugs for Schistosomiasis Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Drugs for Schistosomiasis, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Drugs for Schistosomiasis, Product Type & Application
5.7 Global Key Manufacturers of Drugs for Schistosomiasis, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Drugs for Schistosomiasis Sales by Company
6.1.1.1 North America Drugs for Schistosomiasis Sales by Company (2020-2025)
6.1.1.2 North America Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.1.2 North America Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.1.3 North America Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.1.4 North America Drugs for Schistosomiasis Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Drugs for Schistosomiasis Sales by Company
6.2.1.1 Europe Drugs for Schistosomiasis Sales by Company (2020-2025)
6.2.1.2 Europe Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.2.2 Europe Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.2.3 Europe Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.2.4 Europe Drugs for Schistosomiasis Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Drugs for Schistosomiasis Sales by Company
6.3.1.1 China Drugs for Schistosomiasis Sales by Company (2020-2025)
6.3.1.2 China Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.3.2 China Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.3.3 China Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.3.4 China Drugs for Schistosomiasis Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Drugs for Schistosomiasis Sales by Company
6.4.1.1 Japan Drugs for Schistosomiasis Sales by Company (2020-2025)
6.4.1.2 Japan Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.4.2 Japan Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.4.3 Japan Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.4.4 Japan Drugs for Schistosomiasis Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Drugs for Schistosomiasis Sales by Company
6.5.1.1 India Drugs for Schistosomiasis Sales by Company (2020-2025)
6.5.1.2 India Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.5.2 India Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.5.3 India Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.5.4 India Drugs for Schistosomiasis Major Customer
6.5.5 India Market Trend and Opportunities
6.6 South Korea Market: Players, Segments, Downstream and Major Customers
6.6.1 South Korea Drugs for Schistosomiasis Sales by Company
6.6.1.1 South Korea Drugs for Schistosomiasis Sales by Company (2020-2025)
6.6.1.2 South Korea Drugs for Schistosomiasis Revenue by Company (2020-2025)
6.6.2 South Korea Drugs for Schistosomiasis Sales Breakdown by Type (2020-2025)
6.6.3 South Korea Drugs for Schistosomiasis Sales Breakdown by Application (2020-2025)
6.6.4 South Korea Drugs for Schistosomiasis Major Customer
6.6.5 South Korea Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Shin Poong
7.1.1 Shin Poong Company Information
7.1.2 Shin Poong Business Overview
7.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Shin Poong Drugs for Schistosomiasis Products Offered
7.1.5 Shin Poong Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Business Overview
7.2.3 Merck Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Merck Drugs for Schistosomiasis Products Offered
7.2.5 Merck Recent Development
7.3 Bayer
7.3.1 Bayer Company Information
7.3.2 Bayer Business Overview
7.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Bayer Drugs for Schistosomiasis Products Offered
7.3.5 Bayer Recent Development
7.4 EIPICO
7.4.1 EIPICO Company Information
7.4.2 EIPICO Business Overview
7.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.4.4 EIPICO Drugs for Schistosomiasis Products Offered
7.4.5 EIPICO Recent Development
7.5 Chandra Bhagat Pharma
7.5.1 Chandra Bhagat Pharma Company Information
7.5.2 Chandra Bhagat Pharma Business Overview
7.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Products Offered
7.5.5 Chandra Bhagat Pharma Recent Development
7.6 Taj Pharmaceuticals
7.6.1 Taj Pharmaceuticals Company Information
7.6.2 Taj Pharmaceuticals Business Overview
7.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Products Offered
7.6.5 Taj Pharmaceuticals Recent Development
8 Drugs for Schistosomiasis Manufacturing Cost Analysis
8.1 Drugs for Schistosomiasis Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Drugs for Schistosomiasis
8.4 Drugs for Schistosomiasis Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Drugs for Schistosomiasis Distributors List
9.3 Drugs for Schistosomiasis Customers
10 Drugs for Schistosomiasis Market Dynamics
10.1 Drugs for Schistosomiasis Industry Trends
10.2 Drugs for Schistosomiasis Market Drivers
10.3 Drugs for Schistosomiasis Market Challenges
10.4 Drugs for Schistosomiasis Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Drugs for Schistosomiasis Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Drugs for Schistosomiasis Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Drugs for Schistosomiasis Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Drugs for Schistosomiasis Sales (M Units) by Region (2020-2025)
Table 5. Global Drugs for Schistosomiasis Sales Market Share by Region (2020-2025)
Table 6. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Drugs for Schistosomiasis Revenue Share by Region (2020-2025)
Table 8. Global Drugs for Schistosomiasis Sales (M Units) Forecast by Region (2026-2031)
Table 9. Global Drugs for Schistosomiasis Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Drugs for Schistosomiasis Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Drugs for Schistosomiasis Revenue Share Forecast by Region (2026-2031)
Table 12. Global Drugs for Schistosomiasis Sales by Type (M Units) & (2020-2025)
Table 13. Global Drugs for Schistosomiasis Sales Share by Type (2020-2025)
Table 14. Global Drugs for Schistosomiasis Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Drugs for Schistosomiasis Price by Type (USD/K Units) & (2020-2025)
Table 16. Global Drugs for Schistosomiasis Sales by Type (M Units) & (2026-2031)
Table 17. Global Drugs for Schistosomiasis Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Drugs for Schistosomiasis Price by Type (USD/K Units) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Drugs for Schistosomiasis Sales by Application (M Units) & (2020-2025)
Table 21. Global Drugs for Schistosomiasis Sales Share by Application (2020-2025)
Table 22. Global Drugs for Schistosomiasis Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Drugs for Schistosomiasis Price by Application (USD/K Units) & (2020-2025)
Table 24. Global Drugs for Schistosomiasis Sales by Application (M Units) & (2026-2031)
Table 25. Global Drugs for Schistosomiasis Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Drugs for Schistosomiasis Price by Application (USD/K Units) & (2026-2031)
Table 27. New Sources of Growth in Drugs for Schistosomiasis Application
Table 28. Global Drugs for Schistosomiasis Sales by Company (M Units) & (2020-2025)
Table 29. Global Drugs for Schistosomiasis Sales Share by Company (2020-2025)
Table 30. Global Drugs for Schistosomiasis Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Drugs for Schistosomiasis Revenue Share by Company (2020-2025)
Table 32. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2024)
Table 33. Global Market Drugs for Schistosomiasis Average Price by Company (USD/K Units) & (2020-2025)
Table 34. Global Key Manufacturers of Drugs for Schistosomiasis, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Drugs for Schistosomiasis, Product Type & Application
Table 36. Global Key Manufacturers of Drugs for Schistosomiasis, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 39. North America Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 40. North America Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 42. North America Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 43. North America Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 44. North America Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 45. North America Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 46. Europe Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 47. Europe Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 48. Europe Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 50. Europe Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 51. Europe Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 52. Europe Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 53. Europe Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 54. China Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 55. China Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 56. China Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 58. China Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 59. China Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 60. China Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 61. China Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 62. Japan Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 63. Japan Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 64. Japan Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 66. Japan Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 67. Japan Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 68. Japan Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 69. Japan Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 70. India Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 71. India Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 72. India Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 74. India Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 75. India Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 76. India Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 77. India Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 78. South Korea Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 79. South Korea Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 80. South Korea Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 81. South Korea Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 82. South Korea Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 83. South Korea Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 84. South Korea Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 85. South Korea Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 86. Shin Poong Company Information
Table 87. Shin Poong Description and Business Overview
Table 88. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 89. Shin Poong Drugs for Schistosomiasis Product
Table 90. Shin Poong Recent Development
Table 91. Merck Company Information
Table 92. Merck Description and Business Overview
Table 93. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 94. Merck Drugs for Schistosomiasis Product
Table 95. Merck Recent Development
Table 96. Bayer Company Information
Table 97. Bayer Description and Business Overview
Table 98. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 99. Bayer Drugs for Schistosomiasis Product
Table 100. Bayer Recent Development
Table 101. EIPICO Company Information
Table 102. EIPICO Description and Business Overview
Table 103. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 104. EIPICO Drugs for Schistosomiasis Product
Table 105. EIPICO Recent Development
Table 106. Chandra Bhagat Pharma Company Information
Table 107. Chandra Bhagat Pharma Description and Business Overview
Table 108. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 109. Chandra Bhagat Pharma Drugs for Schistosomiasis Product
Table 110. Chandra Bhagat Pharma Recent Development
Table 111. Taj Pharmaceuticals Company Information
Table 112. Taj Pharmaceuticals Description and Business Overview
Table 113. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 114. Taj Pharmaceuticals Drugs for Schistosomiasis Product
Table 115. Taj Pharmaceuticals Recent Development
Table 116. Production Base and Market Concentration Rate of Raw Material
Table 117. Key Suppliers of Raw Materials
Table 118. Drugs for Schistosomiasis Distributors List
Table 119. Drugs for Schistosomiasis Customers List
Table 120. Drugs for Schistosomiasis Market Trends
Table 121. Drugs for Schistosomiasis Market Drivers
Table 122. Drugs for Schistosomiasis Market Challenges
Table 123. Drugs for Schistosomiasis Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Schistosomiasis Product Picture
Figure 2. Global Drugs for Schistosomiasis Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Drugs for Schistosomiasis Sales Market Share by Type in 2024 & 2031
Figure 4. Praziquantel Product Picture
Figure 5. Oxamniquine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Drugs for Schistosomiasis Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Drugs for Schistosomiasis Sales Market Share by Application in 2024 & 2031
Figure 9. S. haematobium Examples
Figure 10. S. mansoni Examples
Figure 11. S. japonicum Examples
Figure 12. S. mekongi Examples
Figure 13. S. intercalatum Examples
Figure 14. Global Drugs for Schistosomiasis Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Drugs for Schistosomiasis Sales Growth Rate (2020-2031) & (US$ Million)
Figure 16. Global Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 17. Global Drugs for Schistosomiasis Price Trends Growth Rate (2020-2031) & (USD/K Units)
Figure 18. Drugs for Schistosomiasis Report Years Considered
Figure 19. Global Market Drugs for Schistosomiasis Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 20. Global Drugs for Schistosomiasis Revenue Market Share by Region: 2020 VS 2024
Figure 21. North America Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. North America Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 23. Europe Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Europe Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 25. China Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. China Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 27. Japan Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Japan Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 29. India Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 30. India Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 31. South Korea Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 32. South Korea Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 33. Global Drugs for Schistosomiasis Revenue Share by Type (2020-2025)
Figure 34. Global Drugs for Schistosomiasis Sales Share by Type (2026-2031)
Figure 35. Global Drugs for Schistosomiasis Revenue Share by Type (2026-2031)
Figure 36. Global Drugs for Schistosomiasis Revenue Share by Application (2020-2025)
Figure 37. Global Drugs for Schistosomiasis Revenue Growth Rate by Application in 2020 & 2024
Figure 38. Global Drugs for Schistosomiasis Sales Share by Application (2026-2031)
Figure 39. Global Drugs for Schistosomiasis Revenue Share by Application (2026-2031)
Figure 40. Global Drugs for Schistosomiasis Sales Share by Company (2024)
Figure 41. Global Drugs for Schistosomiasis Revenue Share by Company (2024)
Figure 42. Global 5 Largest Drugs for Schistosomiasis Players Market Share by Revenue in Drugs for Schistosomiasis: 2020 & 2024
Figure 43. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 44. Manufacturing Cost Structure of Drugs for Schistosomiasis
Figure 45. Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure 46. Drugs for Schistosomiasis Industrial Chain
Figure 47. Channels of Distribution (Direct Vs Distribution)
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Table 1. Global Drugs for Schistosomiasis Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Drugs for Schistosomiasis Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Drugs for Schistosomiasis Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Drugs for Schistosomiasis Sales (M Units) by Region (2020-2025)
Table 5. Global Drugs for Schistosomiasis Sales Market Share by Region (2020-2025)
Table 6. Global Drugs for Schistosomiasis Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Drugs for Schistosomiasis Revenue Share by Region (2020-2025)
Table 8. Global Drugs for Schistosomiasis Sales (M Units) Forecast by Region (2026-2031)
Table 9. Global Drugs for Schistosomiasis Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Drugs for Schistosomiasis Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Drugs for Schistosomiasis Revenue Share Forecast by Region (2026-2031)
Table 12. Global Drugs for Schistosomiasis Sales by Type (M Units) & (2020-2025)
Table 13. Global Drugs for Schistosomiasis Sales Share by Type (2020-2025)
Table 14. Global Drugs for Schistosomiasis Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Drugs for Schistosomiasis Price by Type (USD/K Units) & (2020-2025)
Table 16. Global Drugs for Schistosomiasis Sales by Type (M Units) & (2026-2031)
Table 17. Global Drugs for Schistosomiasis Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Drugs for Schistosomiasis Price by Type (USD/K Units) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Drugs for Schistosomiasis Sales by Application (M Units) & (2020-2025)
Table 21. Global Drugs for Schistosomiasis Sales Share by Application (2020-2025)
Table 22. Global Drugs for Schistosomiasis Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Drugs for Schistosomiasis Price by Application (USD/K Units) & (2020-2025)
Table 24. Global Drugs for Schistosomiasis Sales by Application (M Units) & (2026-2031)
Table 25. Global Drugs for Schistosomiasis Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Drugs for Schistosomiasis Price by Application (USD/K Units) & (2026-2031)
Table 27. New Sources of Growth in Drugs for Schistosomiasis Application
Table 28. Global Drugs for Schistosomiasis Sales by Company (M Units) & (2020-2025)
Table 29. Global Drugs for Schistosomiasis Sales Share by Company (2020-2025)
Table 30. Global Drugs for Schistosomiasis Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Drugs for Schistosomiasis Revenue Share by Company (2020-2025)
Table 32. Global Drugs for Schistosomiasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Schistosomiasis as of 2024)
Table 33. Global Market Drugs for Schistosomiasis Average Price by Company (USD/K Units) & (2020-2025)
Table 34. Global Key Manufacturers of Drugs for Schistosomiasis, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Drugs for Schistosomiasis, Product Type & Application
Table 36. Global Key Manufacturers of Drugs for Schistosomiasis, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 39. North America Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 40. North America Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 42. North America Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 43. North America Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 44. North America Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 45. North America Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 46. Europe Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 47. Europe Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 48. Europe Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 50. Europe Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 51. Europe Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 52. Europe Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 53. Europe Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 54. China Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 55. China Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 56. China Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 58. China Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 59. China Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 60. China Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 61. China Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 62. Japan Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 63. Japan Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 64. Japan Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 66. Japan Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 67. Japan Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 68. Japan Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 69. Japan Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 70. India Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 71. India Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 72. India Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 74. India Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 75. India Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 76. India Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 77. India Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 78. South Korea Drugs for Schistosomiasis Sales by Company (2020-2025) & (M Units)
Table 79. South Korea Drugs for Schistosomiasis Sales Market Share by Company (2020-2025)
Table 80. South Korea Drugs for Schistosomiasis Revenue by Company (2020-2025) & (US$ Million)
Table 81. South Korea Drugs for Schistosomiasis Revenue Market Share by Company (2020-2025)
Table 82. South Korea Drugs for Schistosomiasis Sales by Type (2020-2025) & (M Units)
Table 83. South Korea Drugs for Schistosomiasis Sales Market Share by Type (2020-2025)
Table 84. South Korea Drugs for Schistosomiasis Sales by Application (2020-2025) & (M Units)
Table 85. South Korea Drugs for Schistosomiasis Sales Market Share by Application (2020-2025)
Table 86. Shin Poong Company Information
Table 87. Shin Poong Description and Business Overview
Table 88. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 89. Shin Poong Drugs for Schistosomiasis Product
Table 90. Shin Poong Recent Development
Table 91. Merck Company Information
Table 92. Merck Description and Business Overview
Table 93. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 94. Merck Drugs for Schistosomiasis Product
Table 95. Merck Recent Development
Table 96. Bayer Company Information
Table 97. Bayer Description and Business Overview
Table 98. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 99. Bayer Drugs for Schistosomiasis Product
Table 100. Bayer Recent Development
Table 101. EIPICO Company Information
Table 102. EIPICO Description and Business Overview
Table 103. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 104. EIPICO Drugs for Schistosomiasis Product
Table 105. EIPICO Recent Development
Table 106. Chandra Bhagat Pharma Company Information
Table 107. Chandra Bhagat Pharma Description and Business Overview
Table 108. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 109. Chandra Bhagat Pharma Drugs for Schistosomiasis Product
Table 110. Chandra Bhagat Pharma Recent Development
Table 111. Taj Pharmaceuticals Company Information
Table 112. Taj Pharmaceuticals Description and Business Overview
Table 113. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2020-2025)
Table 114. Taj Pharmaceuticals Drugs for Schistosomiasis Product
Table 115. Taj Pharmaceuticals Recent Development
Table 116. Production Base and Market Concentration Rate of Raw Material
Table 117. Key Suppliers of Raw Materials
Table 118. Drugs for Schistosomiasis Distributors List
Table 119. Drugs for Schistosomiasis Customers List
Table 120. Drugs for Schistosomiasis Market Trends
Table 121. Drugs for Schistosomiasis Market Drivers
Table 122. Drugs for Schistosomiasis Market Challenges
Table 123. Drugs for Schistosomiasis Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Schistosomiasis Product Picture
Figure 2. Global Drugs for Schistosomiasis Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Drugs for Schistosomiasis Sales Market Share by Type in 2024 & 2031
Figure 4. Praziquantel Product Picture
Figure 5. Oxamniquine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Drugs for Schistosomiasis Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Drugs for Schistosomiasis Sales Market Share by Application in 2024 & 2031
Figure 9. S. haematobium Examples
Figure 10. S. mansoni Examples
Figure 11. S. japonicum Examples
Figure 12. S. mekongi Examples
Figure 13. S. intercalatum Examples
Figure 14. Global Drugs for Schistosomiasis Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Drugs for Schistosomiasis Sales Growth Rate (2020-2031) & (US$ Million)
Figure 16. Global Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 17. Global Drugs for Schistosomiasis Price Trends Growth Rate (2020-2031) & (USD/K Units)
Figure 18. Drugs for Schistosomiasis Report Years Considered
Figure 19. Global Market Drugs for Schistosomiasis Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 20. Global Drugs for Schistosomiasis Revenue Market Share by Region: 2020 VS 2024
Figure 21. North America Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. North America Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 23. Europe Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Europe Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 25. China Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. China Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 27. Japan Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Japan Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 29. India Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 30. India Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 31. South Korea Drugs for Schistosomiasis Revenue (US$ Million) Growth Rate (2020-2031)
Figure 32. South Korea Drugs for Schistosomiasis Sales (M Units) Growth Rate (2020-2031)
Figure 33. Global Drugs for Schistosomiasis Revenue Share by Type (2020-2025)
Figure 34. Global Drugs for Schistosomiasis Sales Share by Type (2026-2031)
Figure 35. Global Drugs for Schistosomiasis Revenue Share by Type (2026-2031)
Figure 36. Global Drugs for Schistosomiasis Revenue Share by Application (2020-2025)
Figure 37. Global Drugs for Schistosomiasis Revenue Growth Rate by Application in 2020 & 2024
Figure 38. Global Drugs for Schistosomiasis Sales Share by Application (2026-2031)
Figure 39. Global Drugs for Schistosomiasis Revenue Share by Application (2026-2031)
Figure 40. Global Drugs for Schistosomiasis Sales Share by Company (2024)
Figure 41. Global Drugs for Schistosomiasis Revenue Share by Company (2024)
Figure 42. Global 5 Largest Drugs for Schistosomiasis Players Market Share by Revenue in Drugs for Schistosomiasis: 2020 & 2024
Figure 43. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 44. Manufacturing Cost Structure of Drugs for Schistosomiasis
Figure 45. Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure 46. Drugs for Schistosomiasis Industrial Chain
Figure 47. Channels of Distribution (Direct Vs Distribution)
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fully Automatic Vehicle Disinfection Equipment Market Research Report 2026
Mar 14, 26
Global Heat Resistant FPC Market Research Report 2026
Mar 14, 26
Global Portable Recording Stick Market Research Report 2026
Mar 14, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232